The primary objective of this study was to determine the relationship between transcutaneous bilirubin (TcB) levels and total serum bilirubin (TSB) levels in extremely preterm infants.
We conducted a prospective multicenter study of extremely preterm infants less than 30 weeks gestation in California. Difference between paired TcB and TSB values were compared based on gestational age, birth weight, maternal race/ethnicity, chronological age as well as during and after phototherapy.
TSB values ranged from 0 to 12.6 mg/dl and the TcB values ranged from 0 to 14.2 mg/dl. TSB was predicted with a high degree of accuracy at TSB = 2.37 + 0.54 (TcB) with r = 0.786. There was good correlation across gestational age, birth weight, race/ethnic, chronological age subgroups as well as during and after phototherapy.
Our study supports the use of TcB as a screening tool for monitoring jaundice in extremely preterm infants.
This is a preview of subscription content, access via your institution
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Get just this article for as long as you need it
Prices may be subject to local taxes which are calculated during checkout
Complete de-identified study data that underlie the results reported in the manuscript will be available upon request. Data requests should be directed to the corresponding author.
Mitra S, Rennie J. Neonatal Jaundice: Aetiology, diagnosis and treatment. Br J Hosp Med. 2017;78:699–704.
Nagar G, Vandermeer B, Campbell S, Kumar M. Effect of Phototherapy on the Reliability of Transcutaneous Bilirubin Devices in Term and Near-Term Infants: A Systematic Review and Meta-Analysis. Neonatology 2016;109:203–12.
Counsilman CE, Heeger LE, Tan R, Bekker V, Zwaginga JJ, Te Pas AB, et al. Iatrogenic blood loss in extreme preterm infants due to frequent laboratory tests and procedures. J Matern Fetal Neonatal Med. 2021;34:2660–65.
Nagar G, Vandermeer B, Campbell S, Kumar M. Reliability of transcutaneous bilirubin devices in preterm infants: a systematic review. Pediatrics 2013;132:871–81.
Schmidt ET, Wheeler CA, Jackson GL, Engle WD. Evaluation of transcutaneous bilirubinometry in preterm neonates. J Perinatol. 2009;29:564–9.
Engle WD, Jackson GL, Engle NG. Transcutaneous bilirubinometry. Semin Perinatol. 2014;38:438–51.
Maisels MJ, Kring E. Transcutaneous bilirubin levels in the first 96 h in a normal newborn population of > or =35 weeks’ gestation. Pediatrics. 2006;117:1169–73.
Maisels MJ, Coffey MP, Kring E. Transcutaneous bilirubin levels in newborns <35 weeks’ gestation. J Perinatol. 2015;35:739–44.
Maisels MJ. Transcutaneous bilirubin measurement: does it work in the real world? Pediatrics 2015;135:364–6.
Maisels MJ, Watchko JF, Bhutani VK, Stevenson DK. An approach to the management of hyperbilirubinemia in the preterm infant less than 35 weeks of gestation. J Perinatol. 2012;32:660–4.
Bhatt DR, Kristensen-Cabrera AI, Lee HC, Weerasinghe S, Stevenson DK, Bhutani VK, et al. Transcutaneous bilirubinometer use and practices surrounding jaundice in 150 California newborn intensive care units. J Perinatol. 2018;38:1532–5.
Chawla D, Jain S, Kaur G, Sinhmar V, Guglani V. Accuracy of transcutaneous bilirubin measurement in preterm low-birth-weight neonates. Eur J Pediatr. 2014;173:173–9.
Chawla D. Transcutaneous Bilirubin for Screening of Significant Jaundice in Very Preterm Neonates. Indian J Pediatr. 2019;86:4.
Raba AA, O’Sullivan A, Miletin J. Transcutaneous bilirubinometry during and after phototherapy in preterm infants: a prospective observational study. BMJ Paediatr Open. 2020;16:4.
Pendse A, Jasani B, Nanavati R, Kabra N. Comparison of Transcutaneous Bilirubin Measurement with Total Serum Bilirubin Levels in Preterm Neonates Receiving Phototherapy. Indian Pediatr. 2017;54:641–3.
Cucuy M, Juster-Reicher A, Flidel O, Shinwell E. Correlation between transcutaneous and serum bilirubin in preterm infants before, during, and after phototherapy. J Matern Fetal Neonatal Med. 2018;10:1323–6.
Bhargava V, Tawfik D, Niebuhr B, Jain SK. Transcutaneous bilirubin estimation in extremely low birth weight infants receiving phototherapy: A prospective observational study. BMC Pediatr. 2018;18:22.
Murli L, Thukral A, Sankar MJ, Vishnubhatla S, Deorari AK, Paul VK, et al. Reliability of transcutaneous bilirubinometry from shielded skin in neonates receiving phototherapy: A prospective cohort study. J Perinatol. 2017;37:182–7.
Costa-Posada U, Concheiro-Guisán A, Táboas-Ledo MF, González-Colmenero E, González-Durán ML, Suarez-Albo M, et al. Accuracy of transcutaneous bilirubin on covered skin in preterm and term newborns receiving phototherapy using a JM-105 bilirubinometer. J Perinatol. 2020;40:226–31.
De Luca D, Dell’Orto V. Patched skin bilirubin assay to monitor neonates born extremely preterm undergoing phototherapy. J Pediatr. 2017;188:122–7.
Fonseca R, Kyralessa R, Malloy M, Richardson J, Jain SK. Covered skin transcutaneous bilirubin estimation is comparable with serum bilirubin during and after phototherapy. J Perinatol. 2012;32:129–31.
Rubio A, Epiard C, Gebus M, Deiber M, Samperiz S, Genty C, et al. Diagnosis Accuracy of Transcutaneous Bilirubinometry in Very Preterm Newborns. Neonatology. 2017;111:1–7.
Arman D, Topcuoğlu S, Gürsoy T, Ovalı F, Karatekin G. The accuracy of transcutaneous bilirubinometry in preterm infants. J Perinatol. 2020;40:212–8.
Yaser A, Tooke L, Rhoda N. Interscapular site for transcutaneous bilirubin measurement in preterm infants: a better and safer screening site. J Perinatol. 2014;34:209–12.
Jeon J, Lim G, Oh KW, Lee NM, Park HW, Chung ML. The forehead is a better site than the sternum to check transcutaneous bilirubin during phototherapy in sick infants. BMC Pediatr. 2020;20:548.
Morris BH, Oh W, Tyson JE, Stevenson DK, Phelps DL, O’Shea TM, et al. NICHD Neonatal Research Network. Aggressive vs. conservative phototherapy for infants with extremely low birth weight. N. Engl J Med. 2008;359:1885–96.
Kaplan M, Bromiker R. Variation in transcutaneous bilirubin nomograms across population groups. J Pediatr. 2019;208:273–8.
Konana OS, Bahr TM, Strike HR, Coleman J, Snow GL, Christensen RD. Decision accuracy and safety of transcutaneous bilirubin screening at intermountain healthcare. J Pediatr. 2021;228:53–57.
Van den Esker-Jonker B, den Boer L, Pepping RM, Bekhof J. Transcutaneous bilirubinometry in jaundiced neonates: A randomized controlled Trial. Pediatrics. 2016;138:e2016–2414.
The authors thank Dr. Jeffrey Maisels for his expert input and guidance. The authors thank Joanne Kuller, Clinical nurse specialist, UCSF Benioff Children’s Oakland & Marcie Portillo, Neonatal Research Institute, Sharp Mary Birch Women & Children’s Hospital for their assistance with the data collection process at their respective centers. We also would like to thank Dr. Robert Kahle, Past President, California Association of Neonatologists (CAN) and CAN Research Committee members for their support with this study.
The authors received no funding to conduct this study.
The authors declare no competing interests.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Sankar, M.N., Ramanathan, R., Joe, P. et al. Transcutaneous bilirubin levels in extremely preterm infants less than 30 weeks gestation. J Perinatol 43, 220–225 (2023). https://doi.org/10.1038/s41372-022-01477-4